Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivoL Tang, L Leong, D Sim, et al.
British Journal of Pharmacology|April 23, 2014
Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulantsF Cattaruzza, S Amadesi, J F Carlsson, et al.
Experimental Cell Research|May 18, 1999
Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1V Pijuan-Thompson, J R Grammer, J Stewart, et al.
European Review for Medical and Pharmacological Sciences|October 31, 2022
Cost-effectiveness analysis of adding omega-3 or vitamin D supplementation to standard therapy in treating painful crises of pediatric sickle cell disease patientsS M Abdelhalima, J E Murphy, M H Meabed, et al.
Chemistry & Biology|July 8, 1998
Lipitoids--novel cationic lipids for cellular delivery of plasmid DNA in vitroC Y Huang, T Uno, J E Murphy, et al.
Journal of Thrombosis and Haemostasis : JTH|May 23, 2013
Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacyA R Brooks, D Sim, U Gritzan, et al.
Journal of Cell Science|May 30, 1998
EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathwayH Xie, M A Pallero, K Gupta, et al.
Nature|April 3, 1986
A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene familyP Besmer, J E Murphy, P C George, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 8, 2017
The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer-a Large Single-Center ExperienceA M Dinaux, R Amri, L G Bordeianou, et al.
Kidney International|June 3, 1999
Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivoC P Hugo, R P Pichler, E Schulze-Lohoff, et al.
Pageof 15